Issue 48, 2014

Design and synthesis of a mitochondria-targeting carrier for small molecule drugs

Abstract

A novel mitochondria-targeting carrier QCy7HA was developed. QCy7HA transported the covalently attached doxorubicin (DOX) to mitochondria specifically. The conjugate limited the effects of P-glycoprotein (Pgp) efflux pumps of multidrug-resistant cells on DOX, indicating that diverting drugs to mitochondria is a potential promising method for treatment of drug-resistant cancers.

Graphical abstract: Design and synthesis of a mitochondria-targeting carrier for small molecule drugs

Supplementary files

Article information

Article type
Communication
Submitted
17 Sep 2014
Accepted
27 Oct 2014
First published
30 Oct 2014

Org. Biomol. Chem., 2014,12, 9793-9796

Author version available

Design and synthesis of a mitochondria-targeting carrier for small molecule drugs

J. Han, T. H. Lee, C. Tung and D. Y. Lee, Org. Biomol. Chem., 2014, 12, 9793 DOI: 10.1039/C4OB01981D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements